Next Study: TRIO 024

Studies & Results

TRIO 025

A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 2 Study of Atezolizumab With or Without Entinostat in Patients with Advanced Triple Negative Breast Cancer, with a Phase 1b Lead in Phase

For information on any of TRIO's clinical trials, please contact Valérie Bee, Director Project Management at